单核多组组学揭示了低氧驱动的血管生成程序及其在鼻腔状细胞癌中的表观遗传控制
Chaelin You1, Jaewoo Park1, Jung Yeon Jang2
1Department of Biological Sciences and Biotechnology, Chungbuk National University, Cheongju, Republic of Korea.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|January 7, 2026
概括
这项研究揭示了与不良结果相关的鼻腔状细胞癌 (SNSCC) 的亚型. 向上腺素/VEGFA轴为这种罕见的癌症提供了一个新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 鼻腔状细胞癌 (SNSCC) 是罕见的,具有未定义的分子驱动因素和瘤微环境 (TME).
- 了解SNSCC的细胞组成和TME对于开发有效的治疗方法至关重要.
研究的目的:
- 通过综合的多原子分析,全面绘制SNSCC生态系统的地图.
- 在SNSCC瘤微环境中识别分子驱动因素和治疗点.
主要方法:
- 综合批量和单核多原子分析 (转录组学,表观组学).
- 在体外功能研究和患者组织的组织学分析.
主要成果:
- 在SNSCC中确定了五种不同的恶性细胞种群,包括与不良结果相关的缺氧 (TC1) 和增殖 (TC2) 亚型.
- TC1细胞通过ADM,MIF和VEGFA分泌驱动缺氧诱导的血管生成,促进内皮细胞尖端 (EC1) 的分化.
- 表观遗传变化,包括DNA低甲基化和AP-1位点的染色质可访问性变化,是这些相互作用的基础,这些相互作用取决于AP-1和HIF1A信号传递.
结论:
- 阐明了SNSCC.中控制瘤-瘤相互作用的表观遗传景观.
- 确立了ADM/VEGFA轴作为一个关键的治疗点,以抑制SNSCC中的表观遗传控制血管生成.
相关概念视频
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Mechanism of Angiogenesis
6.7K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.7K


